Utah’s business landscape is rich with professionals who have le...Read More
Social Media and Employers: Friends or Enemies?
The Case for HSAs
Time to Show Up
Make a Move
In the Lab
Rent to Own
Back from the Dead
A Breath of Fresh Air
Travel & Tourism
Salt Lake City —Catheter Connections, a start-up company co-founded by nurses seeking to reduce deadly hospital-acquired bloodstream infections, announced today that the United States Patent and Trademark Office (USPTO) has issued notices of allowance for patent application numbers 12/917,336 and 12/957,263. Upon issuance of these patents, the company’s patent portfolio will consist of nine U.S. patents directed to its DualCap technology for disinfecting IV connectors — technology that helps protect hospital patients from deadly infections.
Ivera Medical Corporation also has three patents it says cover its Curos disinfectant cap for IV luer access valves. However, during an ongoing inter partes reexamination of these three patents, the USPTO recently issued office actions rejecting, for the second time, all of the contested claims.
“We continue to be confident that upon the conclusion of the reexamination by the USPTO, Ivera will lose its patents for the contested claims,” said Vicki Farrar, CEO of Catheter Connections.